GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (WBO:FRE) » Definitions » EBITDA Margin %

Fresenius SE KGaA (WBO:FRE) EBITDA Margin % : 14.16% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Fresenius SE KGaA EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Fresenius SE KGaA's EBITDA for the three months ended in Dec. 2023 was €804 Mil. Fresenius SE KGaA's Revenue for the three months ended in Dec. 2023 was €5,678 Mil. Therefore, Fresenius SE KGaA's EBITDA margin for the quarter that ended in Dec. 2023 was 14.16%.


Fresenius SE KGaA EBITDA Margin % Historical Data

The historical data trend for Fresenius SE KGaA's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA EBITDA Margin % Chart

Fresenius SE KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.46 19.83 18.52 14.39 12.23

Fresenius SE KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.16 14.58 12.04 6.27 14.16

Competitive Comparison of Fresenius SE KGaA's EBITDA Margin %

For the Medical Care Facilities subindustry, Fresenius SE KGaA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's EBITDA Margin % falls into.



Fresenius SE KGaA EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Fresenius SE KGaA's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=2727/22299
=12.23 %

Fresenius SE KGaA's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=804/5678
=14.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fresenius SE KGaA  (WBO:FRE) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Fresenius SE KGaA EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA (WBO:FRE) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Fresenius SE KGaA (WBO:FRE) Headlines

No Headlines